Suppr超能文献

黏蛋白和 Toll 样受体:感染和癌症中的“黄金搭档”。

Mucins and toll-like receptors: kith and kin in infection and cancer.

机构信息

Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

出版信息

Cancer Lett. 2012 Aug 28;321(2):110-9. doi: 10.1016/j.canlet.2012.01.040. Epub 2012 Feb 3.

Abstract

Inflammation is underlying biological phenomenon common in infection and cancer. Mucins are glycoproteins which establish a physical barrier for undesirable entry of foreign materials through epithelial surfaces. A deregulated expression and an anomalous glycosylation pattern of mucins are known in large number of cancers. TLRs are class of receptors which recognize the molecular patterns of invading pathogens and activate complex inflammatory pathways to clear them. Aberrant expression of TLRs is observed in many cancers. A highly orchestrated action of mucins and TLRs is well evolved host defence mechanism; however, a link between the two in other non-infectious conditions has received less attention. Here we present an overview as to how mucins and TLRs give protection to the host and are deregulated during carcinogenesis. Further, we propose the possible mechanisms of cross-regulation between them in pathogenesis of cancer. As both mucins and TLRs are therapeutically important class of molecules, an understanding of the underlying molecular mechanisms connecting the two will open new avenues for the therapeutic targeting of cancer.

摘要

炎症是感染和癌症中常见的潜在生物学现象。黏蛋白是糖蛋白,可在生理屏障上防止上皮表面的异物进入。大量癌症中黏蛋白的表达失调和异常糖基化模式是已知的。TLRs 是一类受体,可识别入侵病原体的分子模式,并激活复杂的炎症途径将其清除。许多癌症中观察到 TLRs 的异常表达。黏蛋白和 TLRs 的高度协调作用是一种高度进化的宿主防御机制;然而,在其他非传染性疾病中,两者之间的联系受到的关注较少。在这里,我们概述了黏蛋白和 TLRs 如何保护宿主,并在癌变过程中失调。此外,我们还提出了它们在癌症发病机制中相互调控的可能机制。由于黏蛋白和 TLRs 都是具有治疗意义的重要分子类别,因此,了解连接两者的潜在分子机制将为癌症的治疗靶向开辟新途径。

相似文献

3
Toll-like receptors and cancer.Toll样受体与癌症。
Nat Rev Cancer. 2009 Jan;9(1):57-63. doi: 10.1038/nrc2541. Epub 2008 Dec 4.
9
Toll-like receptors in angiogenesis.血管生成中的Toll样受体。
ScientificWorldJournal. 2011 Apr 19;11:981-91. doi: 10.1100/tsw.2011.92.

引用本文的文献

本文引用的文献

3
TLR based therapeutics.基于 Toll 样受体的治疗方法。
Curr Opin Pharmacol. 2011 Aug;11(4):404-11. doi: 10.1016/j.coph.2011.03.004. Epub 2011 Apr 16.
4
Mucin dynamics and enteric pathogens.黏液动态与肠道病原体。
Nat Rev Microbiol. 2011 Apr;9(4):265-78. doi: 10.1038/nrmicro2538.
5
Toll-like receptor modulators: a patent review (2006-2010). Toll 样受体调节剂:专利审查(2006-2010)。
Expert Opin Ther Pat. 2011 Jun;21(6):927-44. doi: 10.1517/13543776.2011.569494. Epub 2011 Mar 15.
7
Pathogen recognition by the innate immune system.先天免疫系统识别病原体。
Int Rev Immunol. 2011 Feb;30(1):16-34. doi: 10.3109/08830185.2010.529976.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验